Safety and efficacy of durvalumab following trimodality therapy for locally advanced esophageal and GEJ adenocarcinoma: Early efficacy results from Big Ten Cancer Research Consortium study.Hirva Mamdani, Shadia I. Jalal, Kenneth A. Kesler et al.|Journal of Clinical Oncology|2019Cited by 10
Gut Microbiota and New Microbiome-Targeted Drugs for Clostridioides difficile InfectionsAhran Lee, Eun-Jeong Yoon|Antibiotics|2024Cited by 4
Safety and efficacy of durvalumab following multimodality therapy for locally advanced esophageal adenocarcinoma: Early results from Big Ten Cancer Research Consortium study.Hirva Mamdani, Shadia I. Jalal, Bryan J. Schneider et al.|Journal of Clinical Oncology|2018Cited by 0